![Jeff Baxter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Baxter
Amministratore Delegato presso
VBI Vaccines (Delaware), Inc.
Profilo
Jeffrey R. Baxter è presidente, amministratore delegato e direttore di VBI Vaccines, Inc., amministratore non esecutivo indipendente di Chromadex Corp., presidente, amministratore delegato e direttore di VBI Vaccines (Delaware), Inc. e presidente, amministratore delegato e direttore di Variation Biotechnologies (US), Inc. Fa parte del consiglio di amministrazione di VBI Vaccines, Inc., Chromadex Corp., VBI Vaccines (Delaware), Inc. e Variation Biotechnologies (US), Inc. Baxter è stato precedentemente impiegato come SVP-Finance, Operations, Research & Development di GlaxoSmithKline Plc, come Principal di British American Tobacco plc, come Managing Partner di The Column Group LLC e come Principal di Unilever Plc. Si è laureato alla Thames Valley University.
Posizioni attive di Jeff Baxter
| Società | Posizione | Inizio |
|---|---|---|
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Presidente | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Amministratore Delegato | 01/07/2014 |
Precedenti posizioni note di Jeff Baxter
| Società | Posizione | Fine |
|---|---|---|
| VBI VACCINES INC. | Amministratore Delegato | 03/01/2025 |
| NIAGEN BIOSCIENCE, INC. | Direttore/Membro del Consiglio | 04/04/2022 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Direttore degli Investimenti | 28/02/2009 |
| GSK PLC | Corporate Officer/Principal | 01/07/2006 |
| UNILEVER PLC | Corporate Officer/Principal | - |
Formazione di Jeff Baxter
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
57
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
British American Tobacco plc
 British American Tobacco plc TobaccoConsumer Non-Durables Manufactures and supplies tobacco products | Consumer Non-Durables |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
University of West London
 University of West London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
